Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients?
- PMID: 12819248
- DOI: 10.1097/01.asn.0000070071.57901.b3
Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients?
Abstract
C-reactive protein is the prototype marker of inflammation and has been shown to predict mortality in hemodialysis patients. However, it remains uncertain as to whether a single C-reactive protein level has similar prognostic significance in peritoneal dialysis patients. A single high-sensitivity C-reactive protein (hs-CRP) level was measured in 246 continuous ambulatory peritoneal dialysis patients without active infections at study baseline together with indices of dialysis adequacy, echocardiographic parameters (left ventricular mass index, left ventricular dimensions, and ejection fraction), nutrition markers (serum albumin, dietary intake, and subjective global assessment) and biochemical parameters (hemoglobin, lipids, calcium, and phosphate). The cohort was then followed-up prospectively for a median of 24 mo (range, 2 to 34 mo), and outcomes were studied in relation to these parameters. Fifty-nine patients died (36 from cardiovascular causes) during the follow-up period. The median hs-CRP level was 2.84 mg/L (range, 0.20 to 94.24 mg/L). Patients were stratified into tertiles according to baseline hs-CRP, namely those with hs-CRP < or = 1.26 mg/L, 1.27 to 5.54 mg/L, and > or = 5.55 mg/L. Those with higher hs-CRP were significantly older (P < 0.001), had greater body mass index (P < 0.001), higher prevalence of coronary artery disease (P = 0.003), and greater left ventricular mass index (P < 0.001). One-year overall mortality was 3.9% (lower) versus 8.8% (middle) versus 21.3% (upper tertile) (P < 0.0001). Cardiovascular death rate was 2.7% (lower) versus 5.2% (middle) versus 16.2% (upper tertile) (P < 0.0001). Multivariable Cox regression analysis showed that every 1 mg/L increase in hs-CRP was independently predictive of higher all-cause mortality (hazard ratio [HR], 1.02; 95% CI, 1.01 to 1.04; P = 0.002) and cardiovascular mortality (HR, 1.03; 95% CI, 1.01 to 1.05; P = 0.001) in peritoneal dialysis patients. Other significant predictors for all-cause mortality included age (HR, 1.07; 95% CI, 1.04 to 1.10), gender (HR, 0.49; 95% CI, 0.27 to 0.90), atherosclerotic vascular disease (HR, 2.65; 95% CI, 1.46 to 4.80), left ventricular mass index (HR, 1.01; 95% CI, 1.00 to 1.01) and residual GFR (HR, 0.53; 95% CI, 0.38 to 0.75). Age (HR, 1.06; 95% CI, 1.02 to 1.10), history of heart failure (HR, 3.31; 95% CI, 1.36 to 8.08), atherosclerotic vascular disease (HR, 3.20; 95% CI, 1.43 to 7.13), and residual GFR (HR, 0.57; 95% CI, 0.38 to 0.86) were also independently predictive of cardiovascular mortality. In conclusion, a single, random hs-CRP level has significant and independent prognostic value in PD patients.
Similar articles
-
Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients.Am J Kidney Dis. 2005 Apr;45(4):715-29. doi: 10.1053/j.ajkd.2004.12.012. Am J Kidney Dis. 2005. PMID: 15806475
-
Association of baseline, longitudinal serum high-sensitive C-reactive protein and its change with mortality in peritoneal dialysis patients.BMC Nephrol. 2017 Jul 4;18(1):211. doi: 10.1186/s12882-017-0624-4. BMC Nephrol. 2017. PMID: 28676043 Free PMC article.
-
High-sensitivity C-reactive protein predicts mortality and technique failure in peritoneal dialysis patients.PLoS One. 2014 Mar 25;9(3):e93063. doi: 10.1371/journal.pone.0093063. eCollection 2014. PLoS One. 2014. PMID: 24667814 Free PMC article.
-
C-reactive protein, inflammation, and coronary risk.Cardiol Clin. 2003 Aug;21(3):315-25. doi: 10.1016/s0733-8651(03)00079-1. Cardiol Clin. 2003. PMID: 14621448 Review.
-
Circulating Inflammatory and Hemostatic Biomarkers are Associated with All-Cause Death and Cancer Death in a Population of Community-Dwelling Japanese: the Tanushimaru Study.Clin Med Insights Cardiol. 2015 Apr 13;8(Suppl 3):43-8. doi: 10.4137/CMC.S17065. eCollection 2014. Clin Med Insights Cardiol. 2015. PMID: 25922585 Free PMC article. Review.
Cited by
-
Gut microbiome dynamics of patients on dialysis: implications for complications and treatment.Front Pharmacol. 2025 Apr 25;16:1470232. doi: 10.3389/fphar.2025.1470232. eCollection 2025. Front Pharmacol. 2025. PMID: 40351408 Free PMC article. Review.
-
Prognostic value of inflammation-based prognostic scores on outcome in patients undergoing continuous ambulatory peritoneal dialysis.BMC Nephrol. 2018 Oct 26;19(1):297. doi: 10.1186/s12882-018-1092-1. BMC Nephrol. 2018. PMID: 30367618 Free PMC article.
-
Dietary Fiber Intake, Myocardial Injury, and Major Adverse Cardiovascular Events Among End-Stage Kidney Disease Patients: A Prospective Cohort Study.Kidney Int Rep. 2019 Mar 20;4(6):814-823. doi: 10.1016/j.ekir.2019.03.007. eCollection 2019 Jun. Kidney Int Rep. 2019. PMID: 31194130 Free PMC article.
-
Risk factors associated with brachial-ankle pulse wave velocity among peritoneal dialysis patients in Macao.BMC Nephrol. 2012 Nov 1;13:143. doi: 10.1186/1471-2369-13-143. BMC Nephrol. 2012. PMID: 23113871 Free PMC article.
-
Longitudinal analysis of cardiac structure and function in incident-automated peritoneal dialysis: comparison between icodextrin solution and glucose-based solution.BMC Nephrol. 2018 May 8;19(1):109. doi: 10.1186/s12882-018-0912-7. BMC Nephrol. 2018. PMID: 29739354 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous